Canopy Growth Introduces Spectrum Therapeutics

SMITHS FALLS, ON, May 7, 2019 /CNW/ – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NYSE: CGC) is pleased to introduce Spectrum Therapeutics, a new global brand that will encompass all of the Company’s ongoing commercial medical and clinical research operations including Spectrum Cannabis, Canopy Health Innovations (CHI), and the most recent addition to Canopy Growth’s medical portfolio, Bionorica SE-founded C3 Cannabinoid Compound Company (“C3“), a European leader in cannabinoid-based medical therapies.

Incorporating these entities into one unified ecosystem will integrate the Company’s medical efforts as one global healthcare enterprise. Spectrum Therapeutics now encompasses the production and distribution of full-spectrum and single cannabinoid medical cannabis products; industry-leading education, resources and support for patients and healthcare practitioners; as well as pre-clinical and clinical research and the development of cannabinoid-based medicines.

The recent acquisition of C3 will allow Spectrum Therapeutics to continue to advance leadership in medical cannabis

... read more at: https://www.newswire.ca/news-releases/canopy-growth-introduces-spectrum-therapeutics-868158927.html

Leave a Reply